Another CSPG4 targeting murine IgG2a antibody, clone 9.2.27, which recognizes a distinct and spatially distant epitope of human CSPG4, was evaluated as a potential treatment against a human melanoma cell line [67]. This evidence concerns the gene CSPG4 and melanoma.